Rüdiger Weseloh

Director/Board Member at NYRADA INC.

Net worth: 666 758 $ as of 2026-07-30

Health Technology

Finance

Consumer Services

Profile

Rüdiger Weseloh currently works at Merck KGaA, as Senior Director-Business Development, EMD Serono, Inc., as Executive Director-Business Development, Nyrada, Inc., as Independent Non-Executive Director from 2019, and Merck Healthcare KGaA, as Senior Director-Global Business Development.
Dr. Weseloh also formerly worked at Gontard & Metallbank AG, as Equity Analyst, Oppenheim Research GmbH, as Analyst, bioXXmed AG, as Member-Supervisory Board, and Merck Serono GmbH, as Head-Business Development.
Dr. Weseloh received his graduate degree from the University of Bayreuth and doctorate degree from Center For Molecular Neurobiology Hamburg.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NYRADA, INC. 1.36%	2026-02-19	1,483,332 ( 1.36% )	666 758 $	2026-07-30

Rüdiger Weseloh active positions

Companies	Position	Start
NYRADA INC.	Director/Board Member	2019-05-31
MERCK KGAA	Corporate Officer/Principal	2005-12-31
Merck Healthcare KGaA Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients	Corporate Officer/Principal	-
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines	Corporate Officer/Principal	-

All active positions of Rüdiger Weseloh

Former positions of Rüdiger Weseloh

Companies	Position	End
Oppenheim Research GmbH Oppenheim Research GmbH Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	2006-07-02
GONTARD & METALLBANK AG	Corporate Officer/Principal	-
Merck Serono GmbH Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products	Corporate Officer/Principal	-
BIOXXMED AG	Director/Board Member	-

See the detail of Rüdiger Weseloh's experience

Training of Rüdiger Weseloh

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rüdiger Weseloh's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Merck KGaA Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products	Health Technology
Gontard & Metallbank AG Gontard & Metallbank AG Major BanksFinance Operates international commercial bank	Finance
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines	Health Technology
University of Bayreuth University of Bayreuth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oppenheim Research GmbH Oppenheim Research GmbH Investment Banks/BrokersFinance Provides brokerage services	Finance
bioXXmed AG bioXXmed AG Pharmaceuticals: MajorHealth Technology Manufactures active ingredients	Health Technology
Merck Serono GmbH Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products	Health Technology
Nyrada, Inc. Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs	Health Technology
Merck Healthcare KGaA Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients	Health Technology
Center For Molecular Neurobiology Hamburg Center For Molecular Neurobiology Hamburg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services